Tuberculosis Research
Research Results
This project is in the development of tools to assess (therapeutic) monitoring of 3 neglected diseases, Leishmaniasis, Tuberculosis and Trachoma. The project is split into 3 workpackages, each addressing one disease.
“The experience that TI Pharma has from putting together partnerships to research neglected diseases is really valuable, because it applies across other therapeutic diseases.”
Tim Wells
Chief Scientific Officer
Medicines for Malaria Venture